ABSTRACT SUBMISSIONS

Participants in the Pipeline and Poster Sessions are drawn from our abstract submission process.

We encourage you to recycle a poster you have or would have presented at SfN, AAN, ANA, CNS, AD/PD, or any other Neurology Scientific Meeting this year. Or simply give a trainee the opportunity to present their data to the ASENT member community.

DOWNLOAD THE ADVANCE PROGRAM

SUBMISSION DEADLINE

Abstract submissions are accepted through December 21, 2021.

LATE BREAKING ABSTRACTS

Late breaking abstracts are accepted through January 15, 2021.

ABOUT ASENT

The American Society for Experimental Neurotherapeutics (ASENT) was established for leaders in academia, government, advocacy and industry who are dedicated to advancing the development of improved therapies for diseases and disorders of the nervous system.

ABOUT THE MEETING

ASENT2021 Annual Meeting will take place Feb 22-25, 2021 as a VIRTUAL CONFERENCE and will offer participants the most current information in the field of neurotherapeutics.

ABSTRACT SUBMISSION CRITERIA

PREVIOUSLY PRESENTED

Abstracts that have been previously presented at other recent scientific meetings, or submitted for consideration to other scientific meetings, CAN be submitted for consideration to ASENT.

WORD COUNT

There is a limit of 3,700 characters for the text of your abstract submission. This includes title, abstract body, and spaces, but does NOT include authors, institutions, tables or images.

TITLE

The title should be entered in mixed case (do not use ALL CAPITAL LETTERS). Do not use formatting tags in the title (with the possible exception of the lower case tag). The title should use capital letters only where appropriate. Do not use abbreviations in the title unless they are universally understood in the field (e.g. EEG, MRI, PET Scan).

STYLE

The abstract should describe original research broadly relevant to the goal of ASENT, which is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system. Please check your abstract carefully for typographical errors, misspellings, etc. Case studies are discouraged but are accepted. Be sure to include data results.

ABSTRACT BODY

The body of the abstract should be one paragraph with no subheadings but organized as follows:

- A sentence stating the study's purpose.

- A brief description of methods.

- A summary of the results.

- A statement of conclusions reached. Do not state simply the "the results will be discussed."

- The body of the abstract should include a maximum of 350 words per abstract.

- Do not include tables or graphs.

- Use of both product and chemical names (capitalized) is acceptable

- Abstracts must be submitted in English and all presentations will be in English.

LITERATURE CITATIONS

Literature citations are ordinarily not provided in abstracts. In cases where citations are necessary, these should be included in the body of the abstract and formatted to include First Author, et al, Journal name, Volume: Pages, and Year.

TABLES AND IMAGES

Do not include figures, images, and tables. These items are not accepted.

ABBREVIATIONS AND REFERENCES

Use standard abbreviations. For terms that are abbreviated, use the whole word the first time, followed by the abbreviation in parenthesis. Abbreviate journal titles according to Index Medicus, and give year, volume number and inclusive pages. Use references sparingly within the body of your abstract. Reference for book chapters should consist of editor, title, city of publication, publisher, year and inclusive pages. References will be included in the total character count.

AUTHORS

Please enter all authors in the order they should appear in the heading of the abstract. The name of the contact author will appear in the first author position and marked as the presenter. List authors in order followed by affiliations, separated by semi-colons.

**In cases where multiple similar submissions are planned, authors should combine their materials into a single, cogent abstract.**

CITATION

All accepted abstracts will be published online in journal, NEUROTHERAPEUTICS, the official journal of the American Society for Experimental Neurotherapeutics, unless the submitting author requests otherwise.

ABSTRACT REVIEW

Abstracts are peer-reviewed by a committee, and all accepted abstracts will be available at the poster sessions. Authors of accepted abstracts will also be considered for a PIPELINE PRESENTATION, which is 5 minutes and 3 slides.

ASENT's Abstract Review Committee will review and make the final decision of abstract approval based on scientific merit and program considerations. ASENT requires that an author attends the Annual Meeting to present the work. If the first author is not planning to attend the Annual Meeting, then a co-author may present the work. Changes in presenter should be emailed to caroline@asent.org and include the abstract title, ID number, and the presenter’s name.

ABSTRACT NOTIFICATION

All submitters will receive notification of the status of their abstracts and presentations for the meeting in January 2021.